Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study
This study is the first to demonstrate the superiority of MMAC to MAC in CBT for hematological malignancies.
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Zimin Sun, Huilan Liu, Chenhui Luo, Liangquan Geng, Changcheng Zheng, Baolin Tang, Xiaoyu Zhu, Juan Tong, Xingbing Wang, Kaiyang Ding, Xiang Wan, Lei Zhang, Wen Yao, Kaiding Song, Xuhan Zhang, Yue Wu, Huizhi Yang, Yongsheng Han, Xin Liu, Weibo Zhu, Jingsh Tags: Cancer Therapy and Prevention Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Clinical Trials | Hematology | Study | Transplants